CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
20 research outputs found
Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
Author
A Torbicki
AGG Turpie
+72Â more
AGG Turpie
AGG Turpie
AJ Camm
AJ Camm
AK Kakkar
AS Go
AT Cohen
BI Eriksson
BI Eriksson
BI Eriksson
BI Eriksson
BI Eriksson
C Kearon
C Weinz
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Kubitza
D Lang
E Perzborn
ED Grech
Executive Steering Committee of behalf of the SPORTIF III Investigators
F Andreotti
G Agnelli
HR Buller
HR BĂĽller
J Graff
J Jiang
J Stampfuss
JL Halperin
JL Mega
JL Mega
JN Fiessinger
JP Bae
JW Eikelboom
L Wallentin
MB Rothberg
MH Prins
MR Lassen
MR Patel
P Théroux
PA Merlini
Paul P. Dobesh
PC Wong
SD Wiviott
T Wilke
The EINSTEIN Investigators
The EINSTEIN–PE Investigators
TJ Wang
Toby Trujillo
W Ageno
W Mueck
W Mueck
W Mueck
W Mueck
W Mueck
W Mueck
W Mueck
WH Geerts
X Zhao
XS Xu
Y Falck-Ytter
Y Miyasaka
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
Efficacy and safety of ximelagatran compared with well controlled warfarin in patients with atrial fibrillation (AR): Observations on age and sex from the SPORTIF trials
Author
Channer K
Ford G
SPORTIF III V Investigators
Publication venue
BMJ Group
Publication date
Field of study
No full text
Newcastle University E-Prints
Effects of age on efficacy and safety of ximelagatran compared with warfarin in atrial fibrillation
Author
Deedwania P
Ford GA
+5Â more
Karalis D
Lindholm CJ
Olsson SB
Pluta W
SPORTIF III &V Investigators
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Newcastle University E-Prints
Anticoagulant management in the cardiovascular setting
Author
ACTIVE Investigators.
Albers
+22Â more
Amadeus
Brouwer
Camm
Connolly
Connolly
Connolly
Dantas
Fuster
Gage
Harenberg
Hart
Lin
Mark
Mega
Merlini
Pisters
Rothberg
Singer
SPORTIF-III III Investigators.
The Executive Steering Committee on behalf of the ROCKET AF Study Investigators.
Wolf
World Health Organization
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Transcatheter occlusion of the left atrial appendage for stroke prevention
Author
Blackshear
Bonow
+22Â more
Executive Steering Committee on behalf of the SPORTIF III Investigators
Fischer
Gage
Gage
Go
Hart
Hart
Horst Sievert
Katz
Madden
Meier
Ostermayer
Sandercock
Sick
Sievert
SPORTIF Executive SteeringCommittee for the SPORTIF V Investigators
Stafford
Stefan H Ostermayer
The Stroke Preventionin Atrial Fibrillation Investigators Committee on Echocardiography
Veinot
Wolf
Yves L Bayard
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial
Author
Active Writing Group of the ACTIVE Investigators
Ahrens I
+19Â more
Carrier M
Connoly S
Douketis JD
Executive Steering Committee SPORTIF III Investigators
Huisman M
James J DiNicolantonio
Kaul S and Diamond GA
Linkins LA
Lippi G
Patel M
Poller L
Poller L
SPORTIF V Investigators
Stangier J
Turpie AG
Uchino K
Wallentin L
Wallentin L
Wolf P
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref
No effect of encapsulation on the pharmacokinetics of warfarin
Author
Bates
Bredberg
+28Â more
Colwell
Da Silva
Eriksson
Eriksson
Executive Steering Committee on behalf of the SPORTIF III Investigators
Francis
Francis
Ginsberg
Gustafsson
Hignite
Hirsh
Kelly
Kim
King
Kong
Milliken
O'Reilly
Palareti
Pinede
Sarich
Sarich
Sarich
Schulman
Teng
The Executive Steering Committee on behalf of the SPORTIF V Investigators
Toon
Wallentin
Yacobi
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Pharmacologic Strategies for the Prevention of Stroke in Patients With Atrial Fibrillation
Author
A Laupacis
BI Eriksson
+29Â more
BI Eriksson
C Gustafsson
D Feng
Executive Steering Committee on behalf of the SPORTIF III Investigators
Greg Flaker
GY Lip
GYH Lip
H Asakura
J Heeringa
J Stangier
JN Fiessinger
K Kumagai
L Wallentin
L Wallentin
RG Hart
Richard Weachter
S Connolly
S Kamath
S Kamath
S Shulman
SJ Connolly
SJ Connolly
SPORTIF Executive Steering Committee for the SPORTIF V Investigators
T Sadangara
The AMADEUS Investigators
The Direct Thrombin Inhibitors Investigators
The Executive Steering Committee on behalf of the ROCKET AF Study Investigators
The RE-MOBILIZE Writing committee
WM Feinberg
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics
Author
Barber
Bernt Kartman
+16Â more
Blann
Bryan
David Brieger
Executive Steering Committee on behalf of the SPORTIF III Investigators
Frew
Gustafsson
Isabelle Mahé
Johannesson
Jonas Carlsson
Lowe
Mark Nevinson
Parry
Sculpher
Stirling Bryan
Sue Jowett
Sweeney
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Novel Oral Anticoagulants
Author
ACUITY Investigators
ADVANCE-2 investigators
+36Â more
Amadeus Investigators
American College of Chest Physicians
American College of Chest Physicians
American College of Chest Physicians
American College of Chest Physicians
American College of Chest Physicians
American College of Chest Physicians
APPRAISE Steering Committee and Investigators
ARG-911 Study Investigators
Argatroban-915 Investigators
ATLAS ACS-TIMI 46 study group
Cardiovascular Disease Educational and Research Trust
ENDORSE Investigators
ESTEEM Investigators
Executive Steering Committee of the SPORTIF III Investigators
EXPERT Study Group
EXPERT Study Investigators
Fixit Study Group
Global Orthopaedic Registry Investigators
Hit Investigators Group
HORIZONS-AMI Trial Investigators
ONYX study group
RE-COVER Study Group
RE-LY Steering Committee and Investigators
RE-MOBILIZE Writing Committee
RE-MODEL Study Group
RE-NOVATE Study Group
RECORD1 Study Group
RECORD2 Investigators
RECORD3 Investigators
RECORD4 Investigators
SEPIA-PCI Trial Investigators
SPORTIF Executive Steering Committee for the SPORTIF V Investigators
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
van Gogh Investigators
van Gogh Investigators
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study
No full text
Crossref
1
2